Читать книгу 40 Years of Continuous Renal Replacement Therapy - Группа авторов - Страница 52

1Wald R, McArthur E, Adhikari NK, Bagshaw SM, Burns KE, Garg AX, Harel Z, Kitchlu A, Mazer CD, Nash DM, et al: Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 2015;65:870–877.

2Clark E, Wald R, Levin A, Bouchard J, Adhikari NK, Hladunewich M, Richardson RM, James MT, Walsh MW, House AA, et al: Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Can J Anaesth 2012;59:861–870.

3Clark E, Wald R, Walsh M, Bagshaw SM; Canadian Acute Kidney Injury (CANAKI) Investigators: Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant 2012;27:2761–2767.

4Kidney Disease Improving Global Outcome: KDIGO clinical practice guideline for acute kidney injury. Kidney International 2012;2(1 suppl):1–138.

5Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM: A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011;15:R72.

6Elseviers MM, Lins RL, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J; SHARF Investigators: Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care 2010;14:R221.

7Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, et al: Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016;375:122–133.

8Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, Ronco C; 17th Acute Disease Quality Initiative (ADQI) Consensus Group: Patient selection and timing of continuous renal replacement therapy. Blood Purif 2016;42:224–237.

9Mendu ML, Ciociolo GR Jr, McLaughlin SR, Graham DA, Ghazinouri R, Parmar S, Grossier A, Rosen R, Laskowski KR, Riella LV, et al: A decision-making algorithm for initiation and discontinuation of RRT in severe AKI. Clin J Am Soc Nephrol 2017;12:228–236.

10Jamale TE, Hase NK, Kulkarni M, Pradeep KJ, Keskar V, Jawale S, Mahajan D: Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial. Am J Kidney Dis 2013;62:1116–1121.

11Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, Thorpe K, McIntyre L, Lamontagne F, Soth M, et al: Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int 2015;88:897–904.

12National Institute for Health and Care Excellence (NICE): Acute kidney injury: prevention, detection and management, 2013. https://www.nice.org.uk/guidance/cg169.

13Vinsonneau C, Allain-Launay E, Blayau C, Darmon M, Ducheyron D, Gaillot T, Honore PM, Javouhey E, Krummel T, Lahoche A, et al: Renal replacement therapy in adult and pediatric intensive care: recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD). Ann Intensive Care 2015;5:58.

14Clec’h C, Darmon M, Lautrette A, Chemouni F, Azoulay E, Schwebel C, Dumenil AS, Garrouste-Orgeas M, Goldgran-Toledano D, Cohen Y, et al: Efficacy of renal replacement therapy in critically ill patients: a propensity analysis. Crit Care 2012;16:R236.

15Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L: Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes area study group on acute renal failure. Am J Respir Crit Care Med 2000;161:872–879.

16Bagshaw SM, Uchino S, Kellum JA, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, et al: Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality. J Crit Care 2013;28:1011–1018.

17Kawarazaki H, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Toki N, Takeda K, Yasuda H, Izawa J, et al: Who may not benefit from continuous renal replacement therapy in acute kidney injury? Hemodial Int 2013;17:624–632.

18Clark EG, Bagshaw SM: Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery. Semin Dial 2015;28:6–11.

19Liborio AB, Leite TT, Neves FM, Teles F, Bezerra CT: AKI complications in critically ill patients: association with mortality rates and RRT. Clin J Am Soc Nephrol 2015;10:21–28.

20Vaara ST, Reinikainen M, Wald R, Bagshaw SM, Pettila V, Group FS: Timing of RRT based on the presence of conventional indications. Clin J Am Soc Nephrol 2014;9:1577–1585.

21Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M: Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 2016;315:2190–2199.

22Bagshaw SM, Wald R: Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury. Kidney Int 2017;91:1022–1032.

23Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002;30:2205–2211.

24Combes A, Brechot N, Amour J, Cozic N, Lebreton G, Guidon C, Zogheib E, Thiranos JC, Rigal JC, Bastien O, et al: Early high-volume hemofiltration versus standard care for post-cardiac surgery shock. The HEROICS study. Am J Respir Crit Care Med 2015;192:1179–1190.

Sean M. Bagshaw, MD, MSc, FRCPC, Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2–124E, Clinical Sciences Building, 8440–112 ST NW, Edmonton, T6G 2B7 (Canada), E-Mail bagshaw@ualberta.ca